Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 29, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

BSAC standardized disc susceptibility testing method (version 10).

J M Andrews1, R A Howe,

  • 1Department of Microbiology, Sandwell and West Birmingham NHS Trust, City Hospital, Birmingham, UK. jenny.andrews1@nhs.net

The Journal of Antimicrobial Chemotherapy
|September 17, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bariatric surgeons' views on pre-operative factors associated with improved health-related quality of life following surgery.

Clinical obesity·2024
Same author

Wharton County Medical Society.

Texas medical journal (Austin, Tex.)·2023
Same author

Association of Health Officers of Texas: Quarantine in Relation to the Present Statute Regulating Same.

Texas medical journal (Austin, Tex.)·2023
Same author

Women and Sanitation.

Texas medical journal (Austin, Tex.)·2023
Same author

Weight and BMI Patterns in a Biologicals-Treated IBD Cohort.

Digestive diseases and sciences·2022
Same author

Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2020
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

The British Society for Antimicrobial Chemotherapy (BSAC) updated antimicrobial susceptibility testing criteria align with EUCAST, removing some agents and discontinuing unreliable glycopeptide testing for staphylococci. Updated tables for anaerobes are now available.

Area of Science:

  • Clinical microbiology
  • Antimicrobial resistance
  • Infectious diseases

Background:

  • The British Society for Antimicrobial Chemotherapy (BSAC) standardized disc susceptibility testing method is widely used.
  • Harmonization with European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines is crucial for consistent antimicrobial susceptibility testing (AST).
  • Changes in interpretative criteria can impact clinical decisions regarding antibiotic treatment.

Purpose of the Study:

  • To update clinicians and researchers on the latest changes in BSAC disc susceptibility testing interpretative criteria.
  • To inform about the harmonization of BSAC criteria with EUCAST MIC breakpoints.
  • To highlight specific changes, including agent removals and method modifications.

Main Methods:

More Related Videos

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

Related Experiment Videos

Last Updated: May 29, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

  • The BSAC disc susceptibility testing method standardization remains unchanged.
  • Interpretative criteria have been revised to align with EUCAST MIC breakpoints.
  • Specific testing protocols, such as for glycopeptides against staphylococci, have been re-evaluated for reliability.

Main Results:

  • Several antimicrobial agents have had their interpretative criteria removed from routine clinical use, with 'Legacy' tables available for research.
  • Disc diffusion testing for glycopeptide susceptibility in staphylococci has been discontinued due to unreliability in detecting low-level resistance.
  • Expanded tables for anaerobes include EUCAST-determined MIC breakpoints, recommending MIC methods due to lack of zone diameter breakpoints.

Conclusions:

  • Clinicians must be aware of the updated BSAC interpretative criteria for accurate AST and appropriate patient management.
  • The removal of certain agents and testing methods underscores the dynamic nature of antimicrobial stewardship and resistance monitoring.
  • Adoption of EUCAST breakpoints and appropriate testing methodologies (e.g., MIC for anaerobes) is essential for effective infectious disease treatment.